AAAAAA
Results:
1-11
|
Results: 11
Authors:
van der Flier, S
van der Kwast, TH
Claassen, CJC
Timmermans, M
Brinkman, A
Henzen-Logmans, SC
Foekens, JA
Dorssers, LCJ
Citation: S. Van Der Flier et al., Immunohistochemical study of the BCAR1/p130Cas protein in non-malignant and malignant human breast tissue, INT J B MAR, 16(3), 2001, pp. 172-178
Authors:
Meijers-Heijboer, H
van Geel, B
van Putten, WLJ
Henzen-Logmans, SC
Seynaeve, C
Menke-Pluymers, MBE
Bartels, CCM
Verhoog, LC
van den Ouweland, AMW
Niermeijer, MF
Brekelmans, CTM
Klijn, JGM
Citation: H. Meijers-heijboer et al., Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation., N ENG J MED, 345(3), 2001, pp. 159-164
Authors:
Schuyer, M
van der Burg, MEL
Henzen-Logmans, SC
Fieret, JH
Klijn, JGM
Look, MP
Foekens, JA
Stoter, G
Berns, EMJJ
Citation: M. Schuyer et al., Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2, BR J CANC, 85(9), 2001, pp. 1359-1367
Authors:
de Kanter, AY
van Geel, AN
Paul, MA
van Eijck, CHJ
Henzen-Logmans, SC
Kruyt, RH
Krenning, EP
Eggermont, AMM
Wiggers, T
Citation: Ay. De Kanter et al., Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control, EUR J SUR O, 26(7), 2000, pp. 652-656
Authors:
Berns, EMJJ
Foekens, JA
Vossen, R
Look, MP
Devilee, P
Henzen-Logmans, SC
van Staveren, IL
van Putten, WLJ
Inganas, M
Meijer-van Gelder, ME
Cornelisse, C
Claassen, CJC
Portengen, H
Bakker, B
Klijn, JGM
Citation: Emjj. Berns et al., Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer, CANCER RES, 60(8), 2000, pp. 2155-2162
Authors:
Foekens, JA
Peters, HA
Look, MP
Portengen, H
Schmitt, M
Kramer, MD
Brunner, N
Janicke, F
Meijer-van Gelder, ME
Henzen-Logmans, SC
van Putten, WLJ
Klijn, JGM
Citation: Ja. Foekens et al., The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients, CANCER RES, 60(3), 2000, pp. 636-643
Authors:
Kuenen-Boumeester, V
Timmermans, AM
De Bruijn, EMCA
Henzen-Logmans, SC
Citation: V. Kuenen-boumeester et al., Immunocytochemical detection of prognostic markers in breast cancer; technical considerations, CYTOPATHOLO, 10(5), 1999, pp. 308-316
Authors:
Schuyer, M
Henzen-Logmans, SC
van der Burg, MEL
Fieret, JH
Derksen, C
Look, MP
Meijer-van Gelder, ME
Klijn, JGM
Foekens, JA
Berns, EMJJ
Citation: M. Schuyer et al., Genetic alterations in ovarian borderline tumours and ovarian carcinomas, EUR J OB GY, 82(2), 1999, pp. 147-150
Authors:
Sieuwerts, AM
Klijn, JGM
Henzen-Logmans, SC
Foekens, JA
Citation: Am. Sieuwerts et al., Cytokine-regulated urokinase-type-plasminogen-activator (uPA) production by human breast fibroblasts in vitro, BREAST CANC, 55(1), 1999, pp. 9-20
Authors:
Kuenen-Boumeester, V
Henzen-Logmans, SC
Timmermans, MM
Van Staveren, IL
Van Geel, A
Peeterse, HJ
Bonnema, J
Berns, EMJJ
Citation: V. Kuenen-boumeester et al., Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast, J PATHOLOGY, 189(2), 1999, pp. 169-175
Authors:
Foekens, JA
Dall, P
Klijn, JGM
Skroch-Angel, P
Claassen, CJC
Look, MP
Ponta, H
Van Putten, WLJ
Herrlich, P
Henzen-Logmans, SC
Citation: Ja. Foekens et al., Prognostic value of CD44 variant expression in primary breast cancer, INT J CANC, 84(3), 1999, pp. 209-215
Risultati:
1-11
|